QXO (QXO) had the highest return in 2012 by a US stock with a market cap of $1B+, returning 8,064,250%.
| ASSET | YEAR | % RETURN |
|---|---|---|
QXO (QXO) | 2012 | 8,064,250% |
Cementos Pacasmayo SAA ADR (CPAC) | 2012 | 17,249.33% |
Par Pacific (PARR) | 2012 | 1,900% |
BioLife Solutions (BLFS) | 2012 | 580% |
Sarepta Therapeutics (SRPT) | 2012 | 465.79% |
ACADIA Pharmaceuticals (ACAD) | 2012 | 322.73% |
Harrow Health (HROW) | 2012 | 306.25% |
Sellas Life Sciences (SLS) | 2012 | 296.04% |
Patrick Industries (PATK) | 2012 | 276.75% |
Astrana Health (ASTH) | 2012 | 237.84% |
Regeneron Pharmaceuticals (REGN) | 2012 | 202.72% |
Vipshop (VIPS) | 2012 | 197.34% |
PulteGroup (PHM) | 2012 | 180.68% |
HCI (HCI) | 2012 | 176.83% |
Builders FirstSource (BLDR) | 2012 | 165.71% |
M/I Homes (MHO) | 2012 | 165.53% |
American Airlines (AAL) | 2012 | 159.62% |
Radian (RDN) | 2012 | 158.61% |
Xpel (XPEL) | 2012 | 155.56% |
AMN Healthcare Services (AMN) | 2012 | 155.53% |
Celldex Therapeutics (CLDX) | 2012 | 153.21% |
CVR Energy (CVI) | 2012 | 152.8% |
IES (IESC) | 2012 | 146.63% |
Himax Technologies (HIMX) | 2012 | 146.57% |
Sharplink Gaming (SBET) | 2012 | 144.83% |